Search
for
Sort by
Research 271–300 of 1000+
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis)
- Relationship Between the Route of Transmission, Environmental Tolerance and Mutation Rate of Some RNA Viruses with Their Pathogenicity
- Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases
- MULTIOMICS – A NEW EXCITING ERA OF RESEARCH
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis).
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Skin Diseases Associated With COVID-19: A Narrative Review
- Current Topics in Post-COVID Syndromes
- Functional medical approach and management for long COVID
- Coronavirus Infection and Cholesterol Metabolism
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Finding Long-COVID: temporal topic modeling of electronic health records from the N3C and RECOVER programs
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Sequelae of long COVID, known and unknown: A review of updated information
- Covid Lines
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Roles of existing drug and drug targets for COVID-19 management
- Comparative analysis of long-term self-reported COVID-19 symptoms among pregnant women
- Caution in the time of rashes and COVID-19
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- Role of ACE2 polymorphism in COVID-19: impact of age
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches